Could the blockbuster class of new GLP-1 diabetes medications help ward off VTEs
When glutathione is found in every cell and plays crucial roles in liver function and immune support, the benefits become clear
Against this background, reports that GLP-1 secretion from L-cells is reduced in patients with type 2 diabetes [10, 11] have prompted several hypotheses about how this affects the estimated clinical effectiveness of these novel drugs
More serious but rare concerns include pancreatitis, gallbladder problems, and potential thyroid tumor risk (observed in rodent studies but not confirmed in humans)
In the meantime, if you have further questions about retatrutide, medical weight loss, or whether one of our currently available therapies may be right for you, use our clinic locator to find a Relive Health center near you to schedule a consultation with a provider